Chicago HOPE Summit

 

One of our radiation oncologists, Gaurav Marwaha, M.D., will be speaking about the rapidly growing role of stereotactic body radiation therapy for lung cancer this weekend at the Chicago HOPE Summit, a survivorship conference that educates, empowers, and creates a community of support for lung cancer survivors.

 

Learn More

 

 

National Radon Action Month

 

Radon is the leading cause of lung cancer deaths among nonsmokers in America and claims the lives of about 21,000 Americans each year.  In fact, the EPA and the U.S. Surgeon General urge all Americans to protect their health by testing their homes, schools, and other buildings for radon. Radon is an invisible, odorless, tasteless […]

 

Learn More

 

 

Rush Radiosurgery Participates in Lung Run Event

 

On September 17, team members from Rush Radiosurgery participated in the 12th annual Chicago Lung Run.  The 10K/5K run or 1 mile walk and rally started at 8:30 a.m. on the city’s beautiful lakefront at Montrose Harbor.  The Chicago Lung Run is held each year in support of lung cancer survivors and their families, and […]

 

Learn More

 

 

Study Says Lung Cancer Survival Increases Sharply If Caught Early

 

According to a recent study in England, increased screening to identify and monitor people at high risk for lung cancer could increase their chance for five-year survival by nearly three-quarters.  Researchers at the University of Liverpool suggest leaders in Britain set up a national screening program to catch more lung cancer earlier, with the hope […]

 

Learn More

 

 

Women’s Lung Health Infographic

 

 

Learn More

 

 

Study Finds CT Scans for Lung Cancer Turn Up Few False-Positives

 

A study recently published in The Annals of Thoracic Surgery, the official journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association, found that false-positive findings for CT-based screening for lung cancer were uncommon.  The results of the study is good news because even though CT-based screening for lung cancer in long-term […]

 

Learn More

 

 

Study Confirms Stereotactic Ablative Radiotherapy Effectiveness for Early-Stage Lung Cancer

 

According to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center, patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT), rather than the current standard […]

 

Learn More

 

 

Treating Lung Cancer with TrueBeam™ STx Technology

 

According to the American Lung Association, lung cancer is the leading cancer killer in both men and women in the United States and causes more deaths than colorectal, breast and prostate cancers combined.  An estimated 158,040 Americans are expected to die from lung cancer in 2015, accounting for approximately 27 percent of all cancer deaths. […]

 

Learn More

 

 

Lung Cancer Retreatment: The Role of TrueBeam STx

 

At Rush Radiosurgery we see a number of lung cancer patients who require retreatment for lung tumors after previously undergoing initial treatment with other forms of therapy. For patients with recurrent lung tumors, stereotactic body radiation therapy (SBRT) has the unique ability to retreat isolated tumor sites with TrueBeam™ STx technology. During treatment, high dose […]

 

Learn More

 

 

Metastatic Breast Cancer Awareness Day: When Breast Cancer Spreads to the Lungs

 

In 2009, the House and Senate voted to designate October 13 as National Metastatic Breast Cancer Awareness Day, a national observance aimed at raising awareness for this advanced form of breast cancer that will affect an estimated 232,670 women in 2014 alone. Rush Radiosurgery urges women to take early detection seriously, as many may be […]

 

Learn More